Read as much as you want on BostonGlobe.com, anywhere and anytime, for just 99¢.

Mass. Movers

Harvard Bioscience stock

Harvard Bioscience develops tools for life-sciences research and regenerative medicine.

Essdras M Suarez/Globe Staff/File 2011

Harvard Bioscience develops tools for life-sciences research and regenerative medicine.

Continue reading below

Harvard Bioscience Inc.’s shares rose 11 cents to $5.01. It’s board of directors this week elected Jeffrey A. Duchemin as chief executive of the Holliston company. The interim CEO, David Green, will continue as president until the spin-off of the regenerative medicine subsidiary, which Green will head. Most recently, Duchemin was global business director for Corning Life Sciences.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week